Starting a career in clinical research is an exciting yet challenging step. Whether you’re fresh out of university or ...

CALIFORNIA CITY, CA / ACCESSWIRE / September 23, 2024 / Perfidy has just released a range of new natural help supplements ...

Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative ...

Recommendation based on a phase 3 study showing a significantly greater proportion of children on Dupixent achieved histological remission, compared to placebo, consistent with improvements seen in ...

Financing led by new investor TCGX, alongside Goldman Sachs Alternatives, Avoro Ventures and venBio·        Funding will support and accelerate development of next-generation multivalent respiratory ...

RIM-TD open-label extension (OLE) study showed long-term improvement of Tardive Dyskinesia (TD) symptoms from treatment with deutetrabenazine over three years in European patients1 TD is an ...

Kate Shaw, founder and CEO of Innovative Trials, a global clinical trial patient recruitment and retention company, has been crowned a top ‘Woman in Pharma’ at the Pharma Industry Awards UK. She was ...

Air transport is a critical lifeline for the life sciences and health care industries, ensuring the timely delivery of essential products like medicines and lab samples worldwide. Whether transporting ...

Approval based on positive results from the IMROZ phase 3 study demonstrating Sarclisa in combination with bortezomib, lenalidomide, and dexamethasone (VRd) significantly improved progression-free ...

Integration of Nova’s BioProfile® FLEX2 will enable automated cell culture analyses for process development through commercial manufacturing with Quantum FlexLakewood, Colorado, U.S., September 23, ...

New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids AstraZeneca’s Fasenra (benralizumab) ...

Extension of indication for Buccolam 10 mg to now include treatment of adults as well as childrenPaves way for the extension of well-established and pan-European market-leading brand to include the ...